Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Is there still a place for anthracyclines in early breast cancer?

Discussion led by Chair 

Date

20 Oct 2023

Session

Is there still a place for anthracyclines in early breast cancer?

Topics

Tumour Site

Breast Cancer

Presenters

Evandro de Azambuja

Authors

E. de Azambuja

Author affiliations

  • Medical Oncology Department, Institute Jules Bordet, 1000 - Brussels/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Presentation by Expert

Presenter: Sara Hurvitz

Session: Is there still a place for anthracyclines in early breast cancer?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.